OpenAlex
Myeloid-derived suppressor cells promote tumor growth and sorafenib resistance by inducing FGF1 upregulation and fibrosis
Work
Year: 2022
Type: article
Abstract: Considerable evidence implicates myeloid-derived suppressor cells (MDSCs) promote tumor progression and drug resistance. Sorafenib is the standard first-line therapy for advanced hepatocellular carcin... more
Source: Neoplasia
Cites: 36
Cited by: 31
Related to: 10
FWCI: 3.82
Citation percentile (by year/subfield): 99.99
Subfield: Immunology
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,500